Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 1
Submit an article Journal homepage
112
Views
32
CrossRef citations to date
0
Altmetric
Research Article

Survival of B Lineage Leukemic Cells: Signals from the Bone Marrow Microenvironment

Laura F. Gibson Departments of Pediatrics and Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV 26506, USA
Pages 19-27 | Published online: 01 Jul 2009

  • Greaves, M. (1999) "Molecular genetics, natural history and the demise of childhood leukaemia", Eur. J. Cancer 35, 173-185.
  • Puj, C.H. and Crist, W.M. (1994) "Biology and treatment of acute lymphoblastic leukemia", J. Pediatr. 124, 491-503.
  • Hoogerbrugge, P.M., Gerritsen, E.J., Docs-Van den Berg, A., Van den Burg, H., Zwinderman, A.H., Hermans, J. and Vossen, J.M. (1995) "Case-control analysis of allogeneic bone marrow transplantation versus maintenance chemotherapy for relapsed ALL in children", Bone Marrow Transplant. 15, 255-259.
  • Manabe, A., Coustan-Smith, E., Behm, F.G., Raimondi, S.C. and Campana, D. (1992) "Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia", Blood 79, 2370-2377.
  • Manabe, A., Murti, K.G., Coustan-Smith, E., Kumagai, M., Behm, F.G., Raimondi, S.C. and Campana, D. (1994) "Adhesiondependent survival of normal and leukemic human B lymphoblasts on bone marrow stromal cells", Blood 83, 758-766.
  • Campana, D., Manabe, A. and Evans, W.E. (1993) "Stromasupported immunocytometric assay (SIA): a novel method for testing the sensitivity of acute lymphoblastic leukemia cells to cytotoxic drugs", Leukemia 7, 482-488.
  • Manabe, A., Coustan-Smith, E., Kumagai, M., Behm, F.G., Raimondi, S.C., Pui, C.H. and Campana, D. (1994) "Interleukin-4 induces programmed cell death (apoptosis) in cases of high-risk acute lymphoblastic leukemia", Blood 83, 731-1737.
  • Kumagai, M., Coustan-Smith, E., Murray, D.J., Silvenninen, O., Murti, K.G., Evans, W.K., Malavasi, F. and Campana, D. (1995) "Ligation of CD38 suppresses human B lymphopoiesis". J. Exp. Med. 181, 1101-1110.
  • Kumagai, M., Manabe, A., Pui, C.H., Behm, F.G., Raimondi, S.C., Hancock, M.L., Mahmoud, H., Crist, W.M. and Campana, D. (1996) "Stroma-supported culture in childhood B lineage acute lymphoblastic leukemia cells predicts treatment outcome", J. Clin. Invest. 97, 755-760.
  • Ashley, D.M., Bol, S.J. and Kannourakis, G. (1995) "Viable bone marrow stromal cells are required for the in vitro survival of B-cell precursor acute lymphoblastic leukemic cells", Leuk. Res. 19, 113-120.
  • Lagneaux, L., Deliorge, A., Bron, D., De Bruyn, C. and Stryckman, P. (1998) "Chronie lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells", Blood 91, 2387-2396.
  • Panayiotidis, P., Jones, D., Ganeshaguru, K., Foroni, L. and Hoffbrand, A.V.) (1996) "Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro", Br. J. Haematol. 92, 97-103.
  • Murti, K.G., Brown, P.S., Kumagai, M. and Campana, D. (1996) "Molecular interactions between human B-cell progenitors and the bone marrow microenvironment", Exp. Cell Res. 226, 47-58.
  • De Waele, M., Renmans, W., Jochmans, K., Schots, R., Lacor, P., Trullemans, F. Otten, J., Balduck, N., Vander Gucht, K., Van Camp. B. and Van Riet. I. (1999) "Different expression of adhesion molecules on CD34+ cells in AML and B-lineage ALL and their normal bone marrow counterparts", Eur. J. Haematol. 63, 192-201.
  • Behr, S.I., Korinth, D. and Schriever, F. (1998) "Differential adhesion pattern of B cell chronic lymphocytic leukemia cells", Leukemia 12, 71-77.
  • Vincent, A.M., Cawley, J.C. and Burthem, J. (1996) "Integrin function in chronic lymphocytic leukemia", Blood 87,4780-4788.
  • Le Bien, T.W. (2000) "Fates of human B-cell precursors", Blood 96, 9-23.
  • Bradstock, K.F. and Gottlieb, D.J. (1995) "Interaction of acute leukemia cells with the bone marrow microenvironment: implications of control of minimal residual disease". Leuk. Lymph. 18, 1-16.
  • Mudry, R.E., Fortney, J.E., York, T., Hall, B.M. and Gibson, L.F. (2000) "Stromal cells regulate survival of B-lineage leukemic cell during chemotherapy", Blood 96, 1926-1932.
  • Kamel-Reid, S., Letarte, M., Doedens, M., Greaves, A., Murdoch, B., Grunberger, T., Lapidot, T., Thorner, P., Freedman, M.I.I. and philips, R.A. (1991) "Bone marrow from children in relapse with per-B acute lymphoblastic leukemia proliferates and disseminates repidly in scid mice", Blood 78, 2973-2981.
  • Jacquy, C., Delepaut, B., Van Daele, S., Vaerman, J.L., Zenebergh, A., Brichard, B., Vermylen, C., Cornu, G. and Martiat, P. (1997) "A prospective study of minimal residual disease in childhood B-lineage acute lymphoblastic leukaemia: MRD level at the end of induction is a strong predictive factor of relapse", Br. J. Haematol. 98, 140-146.
  • Wasserman, R., Galili, N., Ito, Y., Silber, J.H., Reichard, B.A., Shane, S., Womer, R.B., Lange, B. and Rovera, G. (1992) "Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukemia", J. Clin. Oncol. 10, 1879-1888.
  • Campana, D. and Coustan-Smith, E. (1999) "Detection of minimal residual disease in acute leukemia by flow cytometry", Cytometry 38, 139-152.
  • Biondi, A., Valsecchi, M.G., Seriu, T., D' Aniello, E., Willemse, M.J., Fasching, K., Pannunzio, A., Gadner, H., Schrappe, M., Kamps, W.A., Bartram, C.R., van Dongen, J.J. and Panzer- Gurmayer, E.R. (2000) "Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group". Leukemia 14, 1939-1943.
  • Brisco, M.J., Condon, J., Hughes, E., Neoh, S.H., Sykes, P.J., Seshadri, R., Toogood, I., Waters, K., Tauro, G. and Ekert, H. (1994) "Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction (see comments)", Lancet 343, 196-200.
  • Kumagai, M., Manabe, A., Coustan-Smith, E., Blakley, R.L., Beck, W.T., Santana, V.M., Behm, F.G., Raimondi, S.C. and Campana, D.(1994) "Use of stroma-supported cultures of leukemic cells to asses antileukemic drugs. II. Potent cytotoxocity of 2-chlorodeoxyadenosine in acute lymphoblastic leukemia", Leukemia 8, 1116-1123.
  • Wilmanns, C., Fan, D., O'Brian, C.A., Bucana, C.D. and Fidler, I.J. (1992) "Orthotopic and ectopic organ environments differentially influence the sensitivity of murine colon carcinoma cells to doxorubicin and 5-fluorouracil". Int. J. Cancer 52, 98-104.
  • Staroselsky, A.N., Fan, D., O'Brian, C.A., Bucana, C.D., Gupta, K.P. and Fidler, I.J. (1990) "Site-dependent differences in response of the UV-2237 murine fibrosarcoma to systemic therapy with adriamycin", Cancer Res. 50, 7775-7780.
  • Kelley, K.W., Meier, W.A., Minshall, C., Schacher, D.H., Liu, Q., VanHoy, R., Burgess, W. and Dantzer, R. (1998) "Insulin growth factor-I inhibits apoptosis in hematopietic progenitor cells. Implications in thymic aging", Ann. N.Y. Acad. Sci. 840, 518-524.
  • Kelley, K.W., Arkins, S., Minshall, C., Liu, Q. and Dantzer, R. (1996) "Growth hormone, growth factors and hematopoiesis", Horm. Res. 45, 38-45.
  • Kermer, P., Klocker, N., Labes, M. and Bahr, M. (2000) "Insulinlike growth factor-I protects axotomized rat retinal ganglion cells from secondary death via P13-K-dependent Akt phosphorylation and inhibition of caspase-3 in vivo", J. Neurosci. 20, 2-8.
  • Matsuzaki, H., Tamatani, M., Mitsuda, N., Namikawa, K., Kiyama, H., Miyake, S. and Tohyama, M. (1999) "Activation of Akt kinase inhibits apoptosis and changes in Bcl-2 and Bax expression induced by nitric oxide in primary hippocampal neurons". J. Neurochem. 73, 2037-2046.
  • Stagno, F., Cacciola, E., Guglielmo, P., Cacciola, R.R. and Cacciola, E. (1996) "VLA-4 and VLA-5 integrin expression in adult acute lymphoblastic leukemia", Exp. Hematol. 24, 493.
  • Ryan, D.H. (1993) "Adherence of normal and neoplastic human B cell precursors to the bone marrow microenvironment", Blood Cells 19, 225-241.
  • Borghesi, L.A., Smithson, G. and Kincade, P.W. (1997) "Stromal cell modulation of negative regulatory signals that influence apoptosis and proliferation of B lineage lymphocytes", J. Immunol. 159, 4171-4179.
  • Eaves, C.J., Cashman, J.D., Kay, R.J., Dougherty, G.J., Otsuka, T., Gaboury, L.A., Hogge, D.G., Lansdorp, P.M., Eaves, A.C. and Humphries, R.K. (1991) "Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer", Blood 78, 110-117.
  • Hurley, R.W., McCarthy, J.B. and Verfaillie. C.M. (I995) "Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation", J. Clin. Invest. 96, 511-519.
  • Verfaillie, C.M. and Catanzaro,. P. (1996) "Direct contact with stroma inhibits proliferation of human long-term culture initiating cells", Leukemia 10, 498-504.
  • Simmons, P.J., Levesque, J.P. and Zannettino, A.C. (1997) "Adhesion molecules in haemopoiesis", Baillieres Clin. Haematol. 10, 485-505.
  • Prosper, F. and Verfaillie, C.M. (2001) "Regulation of hematopoiesis through adhesion receptors". J. Leukoc. Biol. 69, 307-316.
  • Geijtenbeek, T.B., van Kooyk, Y., van Vliet, S.J., Renes, M.H., Raymakers, R.A. and Figdor, C.G. (1999) "High frequency of adhesion defects in B lineage acute lymphoblastic leukemia". Blood 94, 754-764.
  • Shah, N., Oseth, L. and LeBien, T.W. (1998) "Development of a model for evaluating the interaction between human pre-B acute lymphoblastic leukemic cells and the bone marrow stromal cell microenvironment", Blood 92, 3817-3828.
  • Tsujimoto, Y., Finger, L.R., Yunis, J., Newell, P.C. and Croce, CM. (1984) "Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation", Science 226, 1097-1099.
  • Bakhishi, A., Jensen,. J.P., Goldman, P., Wright, J.J., McBride, O.W., Epstein, A.L. and Korsmeyer, S.J. (1985) "Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18", Cell 41, 899-906.
  • Cleary, M.L. and Sklar, J. (1985) "Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18", Proc. Natl. Acad. Sci. USA 82, 7439-7443.
  • Wyllie, A.M., Kerr, J.F. and Currie, A.R. (1980) "Cell death: the significance of apoptosis", Int. Rev. Cytol. 68, 251-306.
  • Reed, J.C. (1995) "Bcl-2: prevention of apoptosis as a mechanism of drug resistance", Hematol. Oncol. Clin. North Am. 9, 451-473.
  • Boise, L.H., Gonzalaz-Garcia, M., Postema, C.E., Ding, L., Lindsten, T., Turka, L.A., Mao, X., Nunez, G. and Thompson. C.B. (1993) "BcI-x, a Bcl-2-related gene that functions as a dominant regulator of apoptotic cell death". CeII 74, 597-608.
  • Adams, J.M. and Cory, S. (1998) "The Bcl-2 protein family: arbiters of cell survival", Science 281, 1322-1326.
  • Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R.D. and Korsmeyer. S.J., (1990) "Bcl-2 is an inner mitochondrial membrane protein thin blocks programmed cell death". Nature 348, 334-336.
  • Korsmeyer, S.J., Yin, X.M., Oitvai, Z.N., Veis-Novack, D.J. and Linette, G.P. (1995) "Reactive oxygen species and the regulation of cell death by the Bcl-2 gene family", Biochim. Biophys. Acta 1271, 63-66.
  • Miyashita, T. and Reed, J.C. (1993) "Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line", Blood 81, 151-157.
  • Thomas, A., El Rouby, S., Reed,. J.C, Krajewski, S., Silber, R., Potmesil, M. and Newcomb, E.W. (1996) "Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance", Oncogene 12, 1055-1062.
  • McCoukey, D.J., Chandra, J., Wright, S., Plunkett, W., McDonnell, T.J., Reed, J.C. and Keating, M. (1996) "Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX", J. Immunol. 156, 2624-2630.
  • Gibson, L.F., Fortney. J., Magro, G., Ericson, S.G., Lynch, J.P. and Landreth, K.S. (1999) "Regulation of BAX and BCL-2 expression in breast cancer cells by chemotherapy". Breast Cancer Res. Treat. 55, 107-117.
  • Campana, D., Coustan-Smith, E., Manabe, A., Buschle, M,. Raimondi, S.C., Behm, F.C., Ashmun, R., Arico, M., Biondi, A. and Pui, C.H. (1993) "Prolonged survival of B-lineage acute lymphoblastic leukemia cells is accompanied by overexpression of bcl-2 protein", Blood 81, 1025-1031.
  • Gibson, L.F., Piktel, D., Narayanan, R., Nunez, G. and Landreth, K.S. (1996) "Stromal cells regulate bcl-2 and box expression in pro-B cells", Exp. Hematol. 24, 628-637.
  • Nishii, K., Katayama, N., Miwa, H., Shikami, M., Masuya, M., Shiku, H. and Kita, K. (1999) "Survival of human leukaemic B-cell precursors is supported by stromal cells and cytokines: association with the expression of bcl-2 protein". Br. Haematol. 105, 701-710.
  • Uckun, F.M., Yang, Z., Sather, H. Steinherz, P., Nachman, J., Bostrom, B., Crotty, L., Sarquis, M., Ek, O., Zeren, T., Tubergen, D., Reaman, G. and Gaynon, P. (1997) "Cellular expression of antiapoptotic BCL-2 oncoprotein in newly diagnosed childhood acute lymphoblastic leukemia: a Children's Cancer Group Study", Blood 89, 3769-3777.
  • Coustan-Smith, E., Kitanaka, A., Pui, C.H., McNinch, L., Evans, W.E., Raimondi, S.C., Behm, F.G., Arico, M. and Campana, D. (1996) "Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia", Blood 87, 1140-1146.
  • Salomons, G.S., Brady, H.J., Verwijs-Janssen, M., Van Den Berg, J.D., Hart, A.A., Van Den, B.H., Behrendt, H., Hahlen, K. and Smets, L.A. (1997) "The Bax alpha:Bcl-2 ratio modulates the response to dexamethasone in leukaemic cells and is highly variable in childhood acute leukaemia", Int. J. Cancer 71, 959-965.
  • Safomons, G.S., Smets, L.A., Verwijs-Janssen, M., Hart, A.A., Haarman, E.G., Kaspers, G.J., Wering, E.V., Der Does-Van Den Berg, A.V. and Kamps, W.A. (1999) "Bcl-2 family members in childhood acute lymphoblastic leukemia: relationships with features at presentation, in vitro and in vivo drug response and long-term clinical outcome", Leukemia 13, 1574-1580.
  • Jia, L., Macey, M.G., Yin, Y., Newland, A.C. and Kelsey, S.M. (1999) "Subcellular distribution and redistribution of Bcl-2 family proteins in human leukemia cells undergoing apoptosis", Blood 93, 2353-2359.
  • Campos, L., Sabido, O., Viallet, A., Vasselon, C. and Guyotat, D. (1999) "Expression of apoptosis-controlling proteins in acute leukemia cells". Leuk, Lymph. 33, 499-509.
  • Hogarth, L.A. and Hall, A.G. (1999) "Increased BAX expression is associated with an increased risk of relapse in childhood acute lymphocytic leukemia", Blood 93, 2671-2678.
  • Kornblau, S.M., Vu, H.T., Ruvolo, P., Estrov, Z., O'Brien, S., Cortes, J., Kantarjian, H., Andreeff, M. and May, W.S. (2000) "BAX and PKCalpha modulate the prognostic impact of BCL2 expression in acute myelogenous leukemia", Clin. Cancer Res. 6, 1401-1409.
  • Haldar, S., Jena, N. and Croce, C.M. (1995) "Inactivation of Bcl-2 by phosphorylatoin". Proc. Natl. Acad. Sci. USA 92, 4507-4511.
  • Ruvolo, P.P., Deng, X., Carr, B.K. and May, W.S. (1998) "A functional role for mitochondrial protein kinase C alpha in Bcl2 phosphorylation and suppression of apoptosis", J. Biol. Chem. 273, 25436-25442.
  • Ito, T., Deng, X., Carr, B. and May, W.S. (1997) "Bcl-2 phosphorylation required for anti-apoptosis function", J. Biol. Chem. 272, 11671-11673.
  • Thomberry, N.A. and Lazebnik, Y. (1998) "Caspases: enemies within", Science 281, 1312-1316.
  • Blanc, C., Deveraux, Q.L., Krajewski, S., Janicke, R.U., Porter, A.G., Reed, J.C. Jaggi, R. and Marti, A. (2000) "Caspase-3 is essential for procaspase-9 processing and cisplatin-induced apoptosis of MCF-7 breast cancer cells". Cancer Res. 60, 4386-4390.
  • Fadeel, B., Orrenius, S. and Zhivotovsky, B. (2000) "The most unkindest cut of all: on the multiple roles of mammalian caspases", Leukemia 14, 1514-1525.
  • Stennicke, H.R. and Salvesen, G.S. (2000) "Caspeses-controlling intracellular signals by protease zymogea activation", Biochim. Biophys. Acta 1477, 299-306.
  • Eischen, C.M., Kottke, T.J., Martins, L.M., Basi, G.S., Tung, J.S., Earnshaw, W.C., Leibson, P.J. and Kaufmann. S.H. (1997) "Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions". Blood 90, 935-943.
  • Porter, A.G. and Janicke, R.U. (1999) "Emerging roles of caspase-3 in apoptosis", Cell Death Differ. 6, 99-104.
  • Wilson, M.R. (1998) "Apoptosis: unmasking the executioner", Cell Death Differ. 5, 646-652.
  • Slee, E.A., Adrain, C and Martin, S.J. (1999) "Serial killers: ordering caspase activation events in apoptosis", Cell Death Differ. 6, 1067-1074.
  • Wolf, B.B., Schuler, M., Echeverri, F. and Green, D.R. (1999) "Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivation", J. Biol. Chem. 274, 30651-30656.
  • Faderl, S., Thall, P.F., Kantarjian, H.M., Talpaz, M., Harris, D., Van. Q., Beran, M., Kornblau, S.M., Pierce, S. and Estrov, Z. (1999) "Caspasc 2 and caspasc 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemia", Clin. Cancer Res. 5, 4041-4047.
  • Fortney, J.E. and Gibson, L.F. (2001) "Bone Marrow Stromal Cells Regulate Caspase 3 Activity in Leukemic Cells", Leuk. Res. 29, 901-907.
  • Hall, B., Fortney, J. and Gibson, L. (2001) "Alteration of NF-B Expression in Bone Marrow Stromal Cells Treated with Etoposide", Biochem. Pharmacol. 61, 1243-1252.
  • Gibson, L.F., Fortney, J., Landreth, K.S., Piktel, D., Ericson, S.G. and Lynch. J.P. (1997) "Disruption of bone marrow stromal cell function by etoposide", Biol. Blood Marrow Transplant. 3, 122-132.
  • Nagasawa, T., Kikutani, H. and Kishimoto, T. (1994) "Molecular cloning and structure of a pre-B-cell growth-stimulating factor", Proc. Natl. Arad. Sci. USA 91, 2305-2309.
  • Jazin, E.E., Yoo, H., Blomqvist, A.G., Yee, F., Weng, G., Walker, M.W., Salon, J., Larhammar, D. and Wahlestedt, C. (1993) "A proposed bovine neuropeptide Y (NPY) receptor cDNA clone, or its human homologue, confers neither NPY binding sites nor NPY responsiveness on transfected cells", Regul. Pept. 47, 247-258.
  • Nomura, H., Nielsen, B.W. and Matsushima, K. (1993) "Molecular cloning of cDNAs encoding a LD78 receptor and putative leukocyte chemotactic peptide receptors", Int. lmmunol. 5, 1239-1249.
  • Herzog, H., Hort, Y.J., Shine, J. and Selbie, L.A. (1993) "Molecular cloning, characterization, and localization of the human homolog to the reported bovine NPY Y3 receptor: lack of NPY binding and activation", DNA CeII Biol. 12, 465-471.
  • Federsppiel, B., Melhado, I.G., Duncan, A.M., Delaney, A., Schappert, K., Clark-Lewis, I. and Jirik, F.R. (1993) "Molecular cloning of the cDNA and chromosomal localization of the gene for a putative seven-transmembrane segment (7-TMS) receptor isolated from human spleen", Genomics 16, 707-712.
  • Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S., Kitamura, Y., Yoshida, N., Kikutani, H. and Kishimoto, T. (1996) "Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-I", Nature 382, 635-638.
  • Zou, Y.R., Kottmann, A.H., Kuroda, M., Taniuchi, I. and Littman, D.R. (1998) "Function of the chemokine receptor CXCR4 in haematopoiesis und in cercbellar development", Nature 393, 595-599.
  • Ma, Q., Jones, D., Borghesani, P.R., Segal, R.A., Nagasawa, T., Kishimoto, T., Bronson, R.T. and Springer, T.A. (1998) "Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in C", Proc. Natl. Acad. Sci. USA 95, 9448-9453.
  • Aiuti, A., Webb, I.J., Bleul, C., Springer, T. and Gutierrez-Ramos, J.C. (1997) "The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood". J. Exp. Med. 185, 111-120.
  • Bleul, C.C., Fuhlbrigge, R.C., Casasnovas, J.M., Aiuti, A. and Springer, T.A. (1996) "A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)", J. Exp. Med. 184, 1101-1109.
  • D'Apuzzo, M., Rolink, A., Loetscher, M., Hoxie, J.A., Clark-Lewis, I., Melchers, F., Baggiolini, M. and Moser, B. (1997) "The chemokine SDF-1, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4". Eur. J. Immunol. 27, 1788-1793.
  • Lataillade, J.J., Clay, D., Dupuy, C., Rigal, S., Jasmin, C., Bourin, P. and Bousse-Kerdiles, M.C. (2000) "Chemokine SDF-I enhances circulating CD34(+) cell proliferation in synergy with cytokines: possible role in progenitor survival", Blood 95, 756-768.
  • Burger, J.A., Tsukada, N., Burger, M., Zvaifler, N.J., Dell'Aquila, M. and Kipps, T.J. (2000) "Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1", Blood 96, 2655-2663.
  • Majka, M., Ratajczak, J., Kowalska, M.A. and Ratajczak, M.Z. (2000) "Binding of stromal derived factor-lalpha (SDF-lalpha) to CXCR4 chemokine receptor in normal human megakaryoblasis but not in platelets induces phosphorylation of mitogen-activated protein kinase p42/44 (MAPK), ELK-1 transcription factor and serine/threonine kinase AKT", Eur. J. Haematol. 64, 164-172.
  • Peled, A., KoIIe., O., Ponomaryov, T., Petit, I., Franitza, S., Grabovsky, V., Slav, M.M., Nagler, A., Lider, O., Alon, R., Zipori, D. and Lapidot, T. (2000) "The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice", Blood 95, 3289-3296.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.